Charles Nuttens

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Respiratory Syncytial Virus

Top Venues

Infectious diseases and therapy

Vector borne and zoonotic diseases (Larchmont, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Stéphanie Duret, Antoine Bessou, Elisabeth Baux, Jean-François Faucher, Andreas Pilz, Jennifer C Moïsi, James H Stark
Evolution of Lyme Borreliosis Epidemiology in Primary Care and Hospital Settings in France During the COVID-19 Pandemic. Vector borne and zoonotic diseases (Larchmont, N.Y.) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Antoine Bessou, Stéphanie Duret, Jozica Skufca, Emmanuelle Blanc, Andreas Pilz, Bradford D Gessner, Jean-François Faucher, James H Stark
Epidemiology of Lyme Borreliosis in France in Primary Care and Hospital Settings, 2010-2019. Vector borne and zoonotic diseases (Larchmont, N.Y.) 23 (4) (2023)